NeoGenomics Shares Rise on S&P SmallCap 600 Inclusion
09 1월 2019 - 10:16AM
Dow Jones News
By Josh Beckerman
NeoGenomics Inc. (NEO) shares rose 8.4% to $14.25 as S&P Dow
Jones Indices said the genetic testing company will join the
S&P SmallCap 600.
NeoGenomics will join the index before trading opens on Jan. 14,
replacing government-services provider Engility Holdings Inc.
(EGL). In September, Science Applications International Corp.
(SAIC) agreed to buy Engility in a stock deal originally valued at
$1.5 billion.
Last week, Needham & Co. initiated coverage of NeoGenomics
with a Buy rating and a $14 price target.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
January 08, 2019 20:01 ET (01:01 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Engility Holdings, Inc. (NYSE:EGL)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Engility Holdings, Inc. (NYSE:EGL)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024